Greenberg G, Pokress S, Minkin C
Calcif Tissue Int. 1985 Jul;37(4):447-9. doi: 10.1007/BF02553717.
The mechanisms that control cycles of bone formation and bone resorption are not well understood. In this report we provide evidence that compound 48/80 is a potent inhibitor of bone resorption in vitro. Resorption was assessed by the release of calcium-45 from pre-labelled newborn mouse calvaria that were treated with compound 48/80 and/or parathyroid hormone (PTH) in organ culture. Our results demonstrate that co-incubation of calvaria with PTH plus compound 48/80 (concentrations 1-10 mcg/ml) produces a marked reduction of calcium-45 release compared to PTH alone. Furthermore, pre-incubation of calvaria with compound 48/80, for as little as three hours, inhibits resorption by subsequent treatment with PTH alone. Measurement of lactate dehydrogenase (LDH) released into the culture medium indicated that treatment with compound 48/80, at the doses and time periods studied, was not cytotoxic. This novel effect of compound 48/80 may provide a useful tool for studying the cellular mechanisms involved in the bone resorption process.
控制骨形成和骨吸收周期的机制尚未完全明确。在本报告中,我们提供证据表明化合物48/80在体外是一种有效的骨吸收抑制剂。通过在器官培养中用化合物48/80和/或甲状旁腺激素(PTH)处理预先标记的新生小鼠颅骨,评估钙-45的释放来测定骨吸收。我们的结果表明,与单独使用PTH相比,将颅骨与PTH加化合物48/80(浓度为1-10 mcg/ml)共同孵育会使钙-45的释放显著减少。此外,将颅骨与化合物48/80预孵育仅三小时,随后单独用PTH处理即可抑制骨吸收。对释放到培养基中的乳酸脱氢酶(LDH)的测量表明,在所研究的剂量和时间段内,用化合物48/80处理没有细胞毒性。化合物48/80的这种新作用可能为研究骨吸收过程中涉及的细胞机制提供有用的工具。